Giardia lamblia: Epidemiology and Molecular Pathogenesis
Main Article Content
Abstract
Giardia lamblia (synonyms: G. duodenalis and G. intestinalis) is a widespread intestinal protozoan parasite of humans, particularly in settings with inadequate sanitation and poorly protected water sources. This overview examines its transmission, intestinal pathogenesis, clinical manifestations, genetic diversity, host immune responses, and diagnostic approaches. Infection occurs through ingestion of environmentally resistant cysts in contaminated water or food or through direct fecal–oral transmission. Following excystation in the small intestine, trophozoites attach to the intestinal epithelium without typically invading host tissues. Colonization can disrupt epithelial barrier function and impair nutrient absorption. The clinical spectrum ranges from asymptomatic infection to acute or chronic diarrhea, abdominal discomfort, malabsorption, weight loss, and impaired growth in children. The parasite exhibits substantial genetic diversity, with human infections predominantly associated with assemblages A and B, contributing to complex transmission patterns. Parasite persistence and pathogenicity involve variant surface proteins, cysteine proteases, and metabolic adaptations that support immune evasion and intestinal colonization. Host defense depends on coordinated innate and adaptive immune responses, including secretory immunoglobulin A production and CD4+ T-cell-mediated immunity. Diagnostic approaches include stool microscopy, antigen detection assays, and polymerase chain reaction-based methods. Molecular techniques also support parasite genotyping and epidemiological investigations, extending their application beyond the detection of infection. Together, these approaches provide complementary information for examining the occurrence and transmission of giardiasis. Understanding interactions among parasite genetic diversity, virulence mechanisms, and host defenses provides a basis for interpreting clinical variability and infection persistence. The overview highlights the value of integrating parasitological, immunological, and molecular perspectives to strengthen understanding of giardiasis and guide further diagnostic and epidemiological research.
Downloads
Citation Metrics & Similar Scopus Articles
-
Cao X. (2027)Charge-Carrier Behavior and Molecular Interface Engineering in Perovskite Light-Emitting DiodesNano Micro Letters, 19(1)
-
Ni J. (2027)Atomic and Molecular Structure Regulated In Situ Cross-Linked Polyurethane Gel Electrolyte for High-Performance Lithium Metal BatteriesNano Micro Letters, 19(1)
-
Zhang Z. (2027)A green molecular gel nanocomposite: Structure, rheological properties and tribological performanceAdvanced Nanocomposites, 4, 39-50
Article Details

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
References
Adam, R. D. (2001). Biology of Giardia lamblia. Clinical Microbiology Reviews, 14(3), 447–475. https://doi.org/10.1128/CMR.14.3.447-475.2001
Adam, R. D. (2021). Giardia duodenalis: Biology and pathogenesis. Clinical Microbiology Reviews, 34(4), Article e00024-19. https://doi.org/10.1128/CMR.00024-19
Dobell, C. (1960). Antony van Leeuwenhoek and his “little animals”: Being some account of the father of protozoology and bacteriology and his multifarious discoveries in these disciplines. Dover Publications.
World Health Organization. (2011). The control of neglected zoonotic diseases: Community based interventions for NZDs prevention and control. https://www.who.int/publications/i/item/9789241502528
Savioli, L., Smith, H., & Thompson, A. (2006). Giardia and Cryptosporidium join the “Neglected Diseases Initiative.” Trends in Parasitology, 22(5), 203–208. https://doi.org/10.1016/j.pt.2006.02.015
Muhsen, K., & Levine, M. M. (2012). A systematic review and meta-analysis of the association between Giardia lamblia and endemic pediatric diarrhea in developing countries. Clinical Infectious Diseases, 55(Suppl. 4), S271–S293. https://doi.org/10.1093/cid/cis762
Feng, Y., & Xiao, L. (2011). Zoonotic potential and molecular epidemiology of Giardia species and giardiasis. Clinical Microbiology Reviews, 24(1), 110–140. https://doi.org/10.1128/CMR.00033-10
Rendtorff, R. C. (1954). The experimental transmission of human intestinal protozoan parasites. II. Giardia lamblia cysts given in capsules. American Journal of Hygiene, 59(2), 209–222. https://academic.oup.com/aje/article-abstract/59/2/209/89320
Einarsson, E., Ma’ayeh, S., & Svärd, S. G. (2016). An update on Giardia and giardiasis. Current Opinion in Microbiology, 34, 47–52. https://doi.org/10.1016/j.mib.2016.07.019
Halliez, M. C. M., & Buret, A. G. (2013). Extra-intestinal and long-term consequences of Giardia duodenalis infections. World Journal of Gastroenterology, 19(47), 8974–8985. https://doi.org/10.3748/wjg.v19.i47.8974
Monis, P. T., Andrews, R. H., Mayrhofer, G., & Ey, P. L. (1999). Molecular systematics of the parasitic protozoan Giardia intestinalis. Molecular Biology and Evolution, 16(9), 1135–1144. https://doi.org/10.1093/oxfordjournals.molbev.a026207
Thompson, R. C. A., & Monis, P. T. (2004). Variation in Giardia: Implications for taxonomy and epidemiology. Advances in Parasitology, 58, 69–137. https://doi.org/10.1016/S0065-308X(04)58002-8
Cacciò, S. M., & Ryan, U. (2008). Molecular epidemiology of giardiasis. Molecular and Biochemical Parasitology, 160(2), 75–80. https://doi.org/10.1016/j.molbiopara.2008.04.006
Ryan, U., & Cacciò, S. M. (2013). Zoonotic potential of Giardia. International Journal for Parasitology, 43(12–13), 943–956. https://doi.org/10.1016/j.ijpara.2013.06.001
Cotton, J. A., Beatty, J. K., & Buret, A. G. (2011). Host parasite interactions and pathophysiology in Giardia infections. International Journal for Parasitology, 41(9), 925–933. https://doi.org/10.1016/j.ijpara.2011.05.002
Ankarklev, J., Jerlström-Hultqvist, J., Ringqvist, E., Troell, K., & Svärd, S. G. (2010). Behind the smile: Cell biology and disease mechanisms of Giardia species. Nature Reviews Microbiology, 8(6), 413–422. https://doi.org/10.1038/nrmicro2317
Ortega, Y. R., & Adam, R. D. (1997). Giardia: Overview and update. Clinical Infectious Diseases, 25(3), 545–550.
LadyofHats. (2008, August 15). Giardia life cycle [SVG illustration]. Wikimedia Commons. https://commons.wikimedia.org/wiki/File:Giardia_life_cycle_en.svg
Farthing, M. J. G. (1996). Giardiasis. Gastroenterology Clinics of North America, 25(3), 493–515. https://doi.org/10.1016/S0889-8553(05)70260-0
Escobedo, A. A., & Cimerman, S. (2007). Giardiasis: A pharmacotherapy review. Expert Opinion on Pharmacotherapy, 8(12), 1885–1902. https://doi.org/10.1517/14656566.8.12.1885
Roxström-Lindquist, K., Palm, D., Reiner, D., Ringqvist, E., & Svärd, S. G. (2006). Giardia immunity—An update. Trends in Parasitology, 22(1), 26–31. https://doi.org/10.1016/j.pt.2005.11.005
Faubert, G. (2000). Immune response to Giardia duodenalis. Clinical Microbiology Reviews, 13(1), 35–54. https://doi.org/10.1128/CMR.13.1.35
Nash, T. E., Herrington, D. A., Losonsky, G. A., & Levine, M. M. (1987). Experimental human infections with Giardia lamblia. The Journal of Infectious Diseases, 156(6), 974–984. https://doi.org/10.1093/infdis/156.6.974
Buret, A. G. (2008). Pathophysiology of enteric infections with Giardia duodenalis. Parasite, 15(3), 261–265. https://doi.org/10.1051/parasite/2008153261
Luján, H. D., & Svärd, S. G. (Eds.). (2011). Giardia: A model organism. Springer. https://link.springer.com/book/10.1007/978-3-7091-0198-8
Solaymani-Mohammadi, S., & Singer, S. M. (2011). Host immunity and pathogen strain contribute to intestinal disaccharidase impairment following gut infection. The Journal of Immunology, 187(7), 3769–3775. https://doi.org/10.4049/jimmunol.1100606
Sprong, H., Cacciò, S. M., & van der Giessen, J. W. B. (2009). Identification of zoonotic genotypes of Giardia duodenalis. PLOS Neglected Tropical Diseases, 3(12), Article e558. https://doi.org/10.1371/journal.pntd.0000558
Thompson, R. C. A. (2004). The zoonotic significance and molecular epidemiology of Giardia and giardiasis. Veterinary Parasitology, 126(1–2), 15–35. https://doi.org/10.1016/j.vetpar.2004.09.008
Xiao, L., & Fayer, R. (2008). Molecular characterisation of species and genotypes of Cryptosporidium and Giardia. International Journal for Parasitology, 38(11), 1239–1255. https://doi.org/10.1016/j.ijpara.2008.03.006
Robertson, L. J., Hanevik, K., Escobedo, A. A., Mørch, K., & Langeland, N. (2010). Giardiasis—Why do the symptoms sometimes never stop? Trends in Parasitology, 26(2), 75–82.
Baldursson, S., & Karanis, P. (2011). Waterborne transmission of protozoan parasites: Review of worldwide outbreaks—An update 2004–2010. Water Research, 45(20), 6603–6614. https://doi.org/10.1016/j.watres.2011.10.013
Efstratiou, A., Ongerth, J. E., & Karanis, P. (2017). Waterborne transmission of protozoan parasites: Review of outbreaks and lessons learnt. Journal of Water and Health, 15(1), 1–38.
Cacciò, S. M., & Sprong, H. (2011). Epidemiology of giardiasis in humans. In H. D. Luján & S. G. Svärd (Eds.), Giardia: A model organism (pp. 17–28). Springer. https://doi.org/10.1007/978-3-7091-0198-8_2
Helmy, Y. A., Krucken, J., Nöckler, K., von Samson-Himmelstjerna, G., & Zessin, K. H. (2014). Molecular epidemiology of Giardia infections in livestock and companion animals. Parasitology Research, 113(9), 3155–3168. https://doi.org/10.1007/s00436-014-3992-0
Thompson, R. C. A. (2000). Giardiasis as a re-emerging infectious disease and its zoonotic potential. International Journal for Parasitology, 30(12–13), 1259–1267. https://doi.org/10.1016/S0020-7519(00)00127-2
Upcroft, P., & Upcroft, J. A. (2001). Drug targets and mechanisms of resistance in Giardia. Drug Resistance Updates, 4(2), 104–123.
Escobedo, A. A., Almirall, P., Robertson, L. J., Franco, R. M. B., Hanevik, K., Mørch, K., & Cimerman, S. (2010). Giardiasis: The ever-present threat of a neglected disease. Infectious Disorders - Drug Targets, 10(5), 329–348. https://doi.org/10.2174/187152610793180821
Lalle, M. (2010). Giardiasis in the post genomic era: Treatment, drug resistance and novel therapeutic perspectives. Infectious Disorders - Drug Targets, 10(4), 283–294. https://doi.org/10.2174/187152610791591610
Buret, A. G., Hardin, J. A., Olson, M. E., & Gall, D. G. (1992). Mast cell-dependent and independent alterations of smooth muscle contractility during Giardia infection. American Journal of Physiology, 263, G182–G187.
Singer, S. M., & Nash, T. E. (2000). The role of normal flora in Giardia lamblia infections in mice. The Journal of Infectious Diseases, 181(4), 1510–1512. https://doi.org/10.1086/315409






